Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
[Effects of intratumoral injection therapy of dendritic cells combined with hyperthermia for cancer patients]
/in Dendritic Cells, International Publications[Dendritic cells pulsed with glioma RNA induce immunity against intracranial gliomas]
/in Dendritic Cells, Glioblastoma, International PublicationsHost mediated anti-tumor effect of oncolytic Newcastle disease virus after locoregional application
/in International Publications, Newcastle Disease VirusPhase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
/in Dendritic Cells, International Publications, Multiple MyelomaThe ‚kiss of death‘ by dendritic cells to cancer cells
/in Dendritic Cells, International PublicationsTherapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals
/in HIV/AIDS, International PublicationsBreast cancer vaccines: promise for the future or pipe dream?
/in Breast Cancer, International PublicationsVaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein
/in Chronic Virus Hepatitis, International PublicationsNumerical and functional defects of blood dendritic cells in early- and late-stage breast cancer
/in Breast Cancer, Dendritic Cells, International PublicationsDocetaxel weekly regimen in conjunction with RF hyperthermia for pretreated locally advanced non-small cell lung cancer: a preliminary study
/in International Publications, NSCLCRecombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy
/in International Publications, Newcastle Disease VirusPhase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
/in Hypernephroma, International PublicationsImmunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines
/in Colorectal Cancer, International PublicationsApoptic renal carcinoma cells are better inducers of cross-presenting activity than their primary necrotic counterpart
/in Hypernephroma, International PublicationsPhase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage IV renal cell carcinoma
/in Hypernephroma, International PublicationsDendritic cell immunotherapy for stage IV melanoma
/in International Publications, Malignant MelanomaSelected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses
/in International Publications, MicronutrientsMonocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis
/in International Publications, Malignant LymphomaRegression of intestinal adenomas by vaccination with heat shock protein 105-pulsed bone marrow-derived dendritic cells in Apc(Min/+) mice
/in Dendritic Cells, Hyperthermia, International PublicationsLong-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial
/in Cervical Cancer, International Publications